Literature DB >> 33478986

A New Mouse Model Related to SCA14 Carrying a Pseudosubstrate Domain Mutation in PKCγ Shows Perturbed Purkinje Cell Maturation and Ataxic Motor Behavior.

Etsuko Shimobayashi1, Josef P Kapfhammer2.   

Abstract

Spinocerebellar ataxias (SCAs) are diseases characterized by cerebellar atrophy and loss of Purkinje neurons caused by mutations in diverse genes. In SCA14, the disease is caused by point mutations or small deletions in protein kinase C γ (PKCγ), a crucial signaling protein in Purkinje cells. It is still unclear whether increased or decreased PKCγ activity may be involved in the SCA14 pathogenesis. In this study, we present a new knock-in mouse model related to SCA14 with a point mutation in the pseudosubstrate domain, PKCγ-A24E, known to induce a constitutive PKCγ activation. In this protein conformation, the kinase domain of PKCγ is activated, but at the same time the protein is subject to dephosphorylation and protein degradation. As a result, we find a dramatic reduction of PKCγ protein expression in PKCγ-A24E mice of either sex. Despite this reduction, there is clear evidence for an increased PKC activity in Purkinje cells from PKCγ-A24E mice. Purkinje cells derived from PKCγ-A24E have short thickened dendrites typical for PKC activation. These mice also develop a marked ataxia and signs of Purkinje cell dysfunction making them an interesting new mouse model related to SCA. Recently, a similar mutation in a human patient was discovered and found to be associated with overt SCA14. RNA profiling of PKCγ-A24E mice showed a dysregulation of related signaling pathways, such as mGluR1 or mTOR. Our results show that the induction of PKCγ activation in Purkinje cells results in the SCA-like phenotype indicating PKC activation as one pathogenetic avenue leading to a SCA.SIGNIFICANCE STATEMENT Spinocerebellar ataxias (SCAs) are hereditary diseases affecting cerebellar Purkinje cells and are a one of neurodegenerative diseases. While mutation in several genes have been identified as causing SCAs, it is unclear how these mutations cause the disease phenotype. Mutations in PKCγ cause one subtype of SCAs, SCA14. In this study, we have generated a knock-in mouse with a mutation in the pseudosubstrate domain of PKCγ, which keeps PKCγ in the constitutive active open conformation. We show that this mutation leading to a constant activation of PKCγ results in a SCA-like phenotype in these mice. Our findings establish the constant activation of PKC signaling as one pathogenetic avenue leading to an SCA phenotype and a mechanism causing a neurodegenerative disease.
Copyright © 2021 Shimobayashi et al.

Entities:  

Keywords:  ataxic motor behavior; cerebellar Purkinje cell; dendritic development; neurodegenerative diseases; protein kinase C gamma; spinocerebellar ataxia

Year:  2021        PMID: 33478986      PMCID: PMC7939089          DOI: 10.1523/JNEUROSCI.1946-20.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  P/Q-type and T-type calcium channels, but not type 3 transient receptor potential cation channels, are involved in inhibition of dendritic growth after chronic metabotropic glutamate receptor type 1 and protein kinase C activation in cerebellar Purkinje cells.

Authors:  Olivia S Gugger; Jana Hartmann; Lutz Birnbaumer; Josef P Kapfhammer
Journal:  Eur J Neurosci       Date:  2011-12-22       Impact factor: 3.386

Review 2.  Protein kinase C gamma (PKC gamma): function of neuron specific isotype.

Authors:  Naoaki Saito; Yasuhito Shirai
Journal:  J Biochem       Date:  2002-11       Impact factor: 3.387

Review 3.  Mitochondrial dysfunction: cause and consequence of Alzheimer's disease.

Authors:  Kristina Friedland-Leuner; Carola Stockburger; Isabel Denzer; Gunter P Eckert; Walter E Müller
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

Review 4.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

5.  Impaired synapse elimination during cerebellar development in PKC gamma mutant mice.

Authors:  M Kano; K Hashimoto; C Chen; A Abeliovich; A Aiba; H Kurihara; M Watanabe; Y Inoue; S Tonegawa
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

Review 6.  Spinocerebellar ataxia type 14.

Authors:  Dong-Hui Chen; Wendy H Raskind; Thomas D Bird
Journal:  Handb Clin Neurol       Date:  2012

7.  Serines 890 and 896 of the NMDA receptor subunit NR1 are differentially phosphorylated by protein kinase C isoforms.

Authors:  Ana M Sánchez-Pérez; Vicente Felipo
Journal:  Neurochem Int       Date:  2005-07       Impact factor: 3.921

8.  Expression of a protein kinase C inhibitor in Purkinje cells blocks cerebellar LTD and adaptation of the vestibulo-ocular reflex.

Authors:  C I De Zeeuw; C Hansel; F Bian; S K Koekkoek; A M van Alphen; D J Linden; J Oberdick
Journal:  Neuron       Date:  1998-03       Impact factor: 17.173

9.  Sequential posttranslational modifications regulate PKC degradation.

Authors:  Yan Wang; Yangbo Wang; Huijun Zhang; Yingwei Gao; Chao Huang; Aiwu Zhou; Yi Zhou; Yong Li
Journal:  Mol Biol Cell       Date:  2015-11-12       Impact factor: 4.138

10.  Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14.

Authors:  Viorica Chelban; Sarah Wiethoff; Bjørn K Fabian-Jessing; Nourelhoda A Haridy; Alaa Khan; Stephanie Efthymiou; Esther B E Becker; Emer O'Connor; Joshua Hersheson; Katrina Newland; Allan Thomas Hojland; Pernille A Gregersen; Suzanne G Lindquist; Michael B Petersen; Jørgen E Nielsen; Michael Nielsen; Nicholas W Wood; Paola Giunti; Henry Houlden
Journal:  Mov Disord       Date:  2018-03-30       Impact factor: 10.338

View more
  4 in total

1.  Serine/threonine kinase 17b (STK17B) signalling regulates Purkinje cell dendritic development and is altered in multiple spinocerebellar ataxias.

Authors:  Qin-Wei Wu; Josef P Kapfhammer
Journal:  Eur J Neurosci       Date:  2021-09-29       Impact factor: 3.698

Review 2.  Two Sides of the Same Coin: Protein Kinase C γ in Cancer and Neurodegeneration.

Authors:  Caila A Pilo; Alexandra C Newton
Journal:  Front Cell Dev Biol       Date:  2022-06-21

Review 3.  Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?

Authors:  Gema Lordén; Alexandra C Newton
Journal:  Neuronal Signal       Date:  2021-10-08

4.  Transcriptome Profile of a New Mouse Model of Spinocerebellar Ataxia Type 14 Implies Changes in Cerebellar Development.

Authors:  Szilvia E Mezey; Josef P Kapfhammer; Etsuko Shimobayashi
Journal:  Genes (Basel)       Date:  2022-08-09       Impact factor: 4.141

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.